An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Absorption System ◽

Interventional Study ◽

Open Label ◽

Urinary Tract Symptoms ◽

Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects

International Neurourology Journal ◽

10.5213/inj.2010.14.1.7 ◽

2010 ◽

Vol 14 (1) ◽

pp. 7 ◽

Cited By ~ 6

Author(s):

Tae-Beom Kim ◽

Khae-Hawn Kim ◽

Sang-Jin Yoon

Keyword(s):

Urinary Tract ◽

Prospective Study ◽

Erectile Function ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Urinary Tract Symptoms ◽

Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

European Urology Supplements ◽

10.1016/j.eursup.2004.11.001 ◽

2004 ◽

Author(s):

C CHAPPLE ◽

J BOLODEOKU ◽

A QUARTEL ◽

R SNIJDER

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Absorption System ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

Korean Journal of Urology ◽

10.4111/kju.2012.53.3.178 ◽

2012 ◽

Vol 53 (3) ◽

pp. 178 ◽

Cited By ~ 7

Author(s):

Hyo Serk Lee ◽

Sae Woong Kim ◽

Seung-June Oh ◽

Myung-Soo Choo ◽

Kyu-Sung Lee

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Expert Opinion on Drug Metabolism & Toxicology ◽

10.1517/17425255.4.6.771 ◽

2008 ◽

Vol 4 (6) ◽

pp. 771-782 ◽

Cited By ~ 1

Author(s):

Claude C Schulman

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Modified Release ◽

Absorption System ◽

Urinary Tract Symptoms ◽

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

European Urology Supplements ◽

10.1016/j.eursup.2004.10.009 ◽

2005 ◽

Vol 4 (2) ◽

pp. 25-32 ◽

Cited By ~ 12

Author(s):

Christopher R. Chapple ◽

Jerzy Lorenz ◽

Raymond Mortensen ◽

Harald Pauthner ◽

Mario O. Reis ◽

...

Keyword(s):

Urinary Tract ◽

Dose Response ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Absorption System ◽

Urinary Tract Symptoms ◽

Dose Response Study ◽

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

BJU International ◽

10.1111/j.1464-410x.2010.09687.x ◽

2011 ◽

Vol 107 (7) ◽

pp. 1110-1116 ◽

Cited By ~ 65

Author(s):

Craig F. Donatucci ◽

Gerald B. Brock ◽

Evan R. Goldfischer ◽

Peter J. Pommerville ◽

Albert Elion-Mboussa ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Open Label Extension ◽

A randomized, open-label, multicenter study evaluating efficacy of switch from dutasteride to tadalafil in benign prostatic hyperplasia patient with lower urinary tract symptoms (D-to-T trial)

European Urology Supplements ◽

10.1016/s1569-9056(17)30594-8 ◽

2017 ◽

Vol 16 (3) ◽

pp. e928

Author(s):

T. Matsumoto ◽

S. Hatakeyama ◽

K. Yoshikawa ◽

K. Fukui ◽

T. Yanagisawa ◽

...

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Benign Prostatic Hyperplasia Patient ◽

Urinary Tract Symptoms ◽

Erratum: Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: An open label randomised multicentric placebo-controlled clinical trial

Indian Journal of Research in Homoeopathy ◽

10.4103/0974-7168.251920 ◽

2018 ◽

Vol 12 (4) ◽

pp. 250

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Clinical Trial ◽

Open Label ◽

Urinary Tract Symptoms ◽

Re: Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A 1-Year, Open-Label Extension Study

The Journal of Urology ◽

10.1016/j.juro.2011.08.004 ◽

2011 ◽

Vol 186 (5) ◽

pp. 1985-1985

Author(s):

Allen D. Seftel

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Open Label Extension ◽

Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: An open label randomised multicentric placebo-controlled clinical trial

Indian Journal of Research in Homoeopathy ◽

10.4103/ijrh.ijrh_36_18 ◽

2018 ◽

Vol 12 (3) ◽

pp. 113

Author(s):

Pritha Mehra ◽

Varanasi Roja ◽

Bindu Sharma ◽

Praveen Oberai ◽

G. R. C. Reddy ◽

...

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Clinical Trial ◽

Open Label ◽

Urinary Tract Symptoms ◽